| 國立成功大學 |
2023 |
Switching to coformulated bictegravir, emtricitabine, and tenofovir alafenamide maintained viral suppression in adults with historical virological failures and K65N/R mutation
|
Tsai, M.-S.;Sun, H.-Y.;Chen, Chen C.-P.;Lee, C.-H.;Lee, C.-Y.;Liu, C.-E.;Tang, H.-J.;Hung, T.-C.;Li, C.-W.;Lee, Y.-T.;Liou, B.-H.;Yang, C.-J.;Hung, C.-C. |
| 國立成功大學 |
2023 |
Optimal Frequency of Hepatitis C Virus (HCV) RNA Testing for Detection of Acute HCV Infection Among At-risk People With Human Immunodeficiency Virus: A Multicenter Study
|
Sun, H.-Y.;Liou, B.-H.;Chen, T.-C.;Yang, C.-J.;Huang, S.-H.;Lu, P.-L.;Huang, C.-H.;Tsai, M.-S.;Cheng, S.-H.;Lee, N.-Y.;Ko, W.-C.;Chen, Y.-H.;Liu, W.-D.;Lin, S.-Y.;Lin, S.-P.;Chen, P.-L.;Syue, L.-S.;Huang, Y.-S.;Chuang, Y.-C.;Chen, Chen C.-B.;Chang, Y.-T.;Lee, Y.-T.;Hsieh, S.-M.;Su, L.-H.;Cheng, Cheng C.-Y.;Hung, C.-C. |
| 臺大學術典藏 |
2022-09-16T08:49:04Z |
Short-course daily isoniazid and rifapentine for latent tuberculosis infection in people living with HIV who received coformulated bictegravir/emtricitabine/tenofovir alafenamide
|
Liou B.-H.; Cheng C.-N.; Lin Y.-T.; Lin Y.-J.; Chuang Y.-C.; Lin K.-Y.; Liu W.-C.; Lin S.-W.; CHING-HUA KUO; Sun H.-Y.; Hung C.-C. |
| 臺大學術典藏 |
2022-09-15T05:50:19Z |
Hepatitis C microelimination among people living with HIV in Taiwan
|
Chen G.-J.; Ho S.-Y.; Su L.-H.; Chang S.-Y.; Hsieh S.-M.; Sheng W.-H.; WANG-DA LIU; Huang Y.-S.; Lin K.-Y.; Chen Y.-T.; Su Y.-C.; Liu W.-C.; Sun H.-Y.; Hung C.-C. |
| 臺大學術典藏 |
2022-09-15T05:50:18Z |
Effectiveness of COVID-19 vaccination among people living with HIV during a COVID-19 outbreak
|
Lin K.-Y.; Wu P.-Y.; WANG-DA LIU; Sun H.-Y.; Hsieh S.-M.; Sheng W.-H.; Huang Y.-S.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2022-09-15T05:50:17Z |
Low-level viraemia and virologic failure among people living with HIV who received maintenance therapy with co-formulated bictegravir, emtricitabine and tenofovir alafenamide versus dolutegravir-based regimens
|
Chen G.-J.; Sun H.-Y.; Chen L.-Y.; Hsieh S.-M.; Sheng W.-H.; WANG-DA LIU; Chuang Y.-C.; Huang Y.-S.; Lin K.-Y.; Wu P.-Y.; Chang H.-Y.; Luo Y.-Z.; Su Y.-C.; Liu W.-C.; Chang S.-F.; Chang S.-Y.; Hung C.-C. |
| 臺大學術典藏 |
2022-09-15T05:50:17Z |
Performance of Hepatitis C Virus (HCV) Core Antigen Assay in the Diagnosis of Recently Acquired HCV Infection among High-Risk Populations
|
Sun H.-Y.; WANG-DA LIU; Wang C.-W.; Wei Y.-J.; Lin K.-Y.; Huang Y.-S.; Su L.-H.; Chen Y.-T.; Liu W.-C.; Su Y.-C.; Chen Y.-W.; Chuang Y.-C.; Lu P.-L.; Hung C.-C.; Yu M.-L. |
| 臺大學術典藏 |
2022-09-15T05:42:30Z |
Sexually-transmitted hepatitis C virus reinfections among people living with HIV in Taiwan: the emerging role of genotype 6
|
Chen G.-J.; Sun H.-Y.; Chang S.-Y.; Su L.-H.; Chen Y.-T.; Hsieh S.-M.; Liu W.-D.; Sheng W.-H.; Huang Y.-S.; Lin K.-Y.; Su Y.-C.; Liu W.-C.; CHIEN-CHING HUNG |
| 臺大學術典藏 |
2022-09-15T05:42:29Z |
Participation in cancer screening among people living with HIV at a university hospital
|
Wu P.-Y.; Sun H.-Y.; Chen M.-Y.; Sheng W.-H.; Hsieh S.-M.; Chuang Y.-C.; Chang H.-Y.; Luo Y.-Z.; Zhang J.-Y.; CHIEN-CHING HUNG |
| 臺大學術典藏 |
2022-09-15T05:42:29Z |
Hepatitis C microelimination among people living with HIV in Taiwan
|
Chen G.-J.; Ho S.-Y.; Su L.-H.; Chang S.-Y.; Hsieh S.-M.; Sheng W.-H.; Liu W.-D.; Huang Y.-S.; Lin K.-Y.; Chen Y.-T.; Su Y.-C.; Liu W.-C.; Sun H.-Y.; CHIEN-CHING HUNG |
| 臺大學術典藏 |
2022-09-15T05:42:28Z |
Real-world effectiveness of direct-acting antivirals in people living with human immunodeficiency virus and hepatitis C virus genotype 6 infections
|
Sun H.-Y.; Cheng C.-Y.; Lin C.-Y.; Yang C.-J.; Lee N.-Y.; Liou B.-H.; Tang H.-J.; Liu Y.-M.; Lee C.-Y.; Chen T.-C.; Huang Y.-C.; Lee Y.-T.; Tsai M.-J.; Lu P.-L.; Tsai H.-C.; Wang N.-C.; Hung T.-C.; Cheng S.-H.; CHIEN-CHING HUNG |
| 臺大學術典藏 |
2022-09-15T05:42:27Z |
Incidence of low-level viremia and its impact on virologic failure among people living with HIV-1 who switched to elvitegravir-based antiretroviral therapy
|
Hsu J.-Y.; Sun H.-Y.; Hsieh T.-W.; Chang S.-Y.; Chuang Y.-C.; Huang Y.-S.; Hsiao C.-Y.; Su Y.-C.; Liu W.-C.; Chang S.-F.; CHIEN-CHING HUNG |
| 臺大學術典藏 |
2022-09-15T05:42:26Z |
Three-Stage Pooled Plasma Hepatitis C Virus RNA Testing for the Identification of Acute HCV Infections in At-Risk Populations
|
Sun H.-Y.; Chiang C.; Huang S.-H.; Guo W.-J.; Chuang Y.-C.; Huang Y.-C.; Yang C.-J.; Su L.-H.; Chen Y.-T.; Chen Y.-W.; Hsu F.-C.; Ho S.-Y.; Liu W.-C.; Su Y.-C.; Chang S.-Y.; Hsiao C.-F.; CHIEN-CHING HUNG; Yu M.-L. |
| 臺大學術典藏 |
2022-09-15T05:42:26Z |
Effectiveness of COVID-19 vaccination among people living with HIV during a COVID-19 outbreak
|
Lin K.-Y.; Wu P.-Y.; Liu W.-D.; Sun H.-Y.; Hsieh S.-M.; Sheng W.-H.; Huang Y.-S.; CHIEN-CHING HUNG; Chang S.-C. |
| 臺大學術典藏 |
2022-09-15T05:42:25Z |
Hepatitis C Virus Reinfection in People With HIV in Taiwan After Achieving Sustained Virologic Response With Antiviral Treatment: The RECUR Study
|
Liu C.-H.; Sun H.-Y.; Peng C.-Y.; Hsieh S.-M.; Yang S.-S.; Kao W.-Y.; Shih Y.-L.; Lin C.-L.; Liu C.-J.; Sheng W.-H.; Lo Y.-C.; Liu W.-C.; Wu J.-H.; Su T.-H.; Tseng T.-C.; Chen P.-J.; CHIEN-CHING HUNG; Kao J.-H. |
| 臺大學術典藏 |
2022-09-15T05:42:25Z |
Performance of Hepatitis C Virus (HCV) Core Antigen Assay in the Diagnosis of Recently Acquired HCV Infection among High-Risk Populations
|
Sun H.-Y.; Liu W.-D.; Wang C.-W.; Wei Y.-J.; Lin K.-Y.; Huang Y.-S.; Su L.-H.; Chen Y.-T.; Liu W.-C.; Su Y.-C.; Chen Y.-W.; Chuang Y.-C.; Lu P.-L.; CHIEN-CHING HUNG; Yu M.-L. |
| 臺大學術典藏 |
2022-09-15T05:42:24Z |
Low-level viraemia and virologic failure among people living with HIV who received maintenance therapy with co-formulated bictegravir, emtricitabine and tenofovir alafenamide versus dolutegravir-based regimens
|
Chen G.-J.; Sun H.-Y.; Chen L.-Y.; Hsieh S.-M.; Sheng W.-H.; Liu W.-D.; Chuang Y.-C.; Huang Y.-S.; Lin K.-Y.; Wu P.-Y.; Chang H.-Y.; Luo Y.-Z.; Su Y.-C.; Liu W.-C.; Chang S.-F.; Chang S.-Y.; CHIEN-CHING HUNG |
| 臺大學術典藏 |
2022-09-09T04:21:39Z |
Evolution of estimated glomerular filtration rate in human immunodeficiency virus and hepatitis C virus-coinfected patients receiving sofosbuvir-based direct-acting antivirals and antiretroviral therapy
|
Liu C.-H.; Sun H.-Y.; Hsieh S.-M.; Liu W.-C.; Sheng W.-H.; Liu C.-J.; Su T.-H.; Tseng T.-C.; Chen P.-J.; Hung C.-C.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-09-09T04:21:16Z |
Hepatitis C Virus Reinfection in People With HIV in Taiwan After Achieving Sustained Virologic Response With Antiviral Treatment: The RECUR Study
|
Liu C.-H.; Sun H.-Y.; Peng C.-Y.; Hsieh S.-M.; Yang S.-S.; Kao W.-Y.; Shih Y.-L.; Lin C.-L.; Liu C.-J.; Sheng W.-H.; Lo Y.-C.; Liu W.-C.; Wu J.-H.; Su T.-H.; Tseng T.-C.; Chen P.-J.; Hung C.-C.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-09-07T06:39:28Z |
Simultaneous quantification of antimicrobial agents for multidrug-resistant bacterial infections in human plasma by ultra-high-pressure liquid chromatography-tandem mass spectrometry
|
Tsai I.-L.; Sun H.-Y.; Chen G.-Y.; SHU-WEN LIN; Kuo C.-H. |
| 臺大學術典藏 |
2022-09-07T06:39:26Z |
Therapeutic drug monitoring and pharmacogenetic, study of HIV-infected ethnic chinese receiving efavirenz-containing antiretroviral therapy with or without rifampicin-based anti-tuberculous therapy
|
Lee K.-Y.; SHU-WEN LIN; Sun H.-Y.; Kuo C.-H.; Tsai M.-S.; Wu B.-R.; Tang S.-Y.; Liu W.-C.; Chang S.-Y.; Hung C.-C. |
| 臺大學術典藏 |
2022-09-07T06:39:23Z |
Development and validation of a high-performance liquid chromatography-fluorescence detection method for the accurate quantification of colistin in human plasma
|
Chepyala D.; Tsai I.-L.; Sun H.-Y.; SHU-WEN LIN; Kuo C.-H. |
| 臺大學術典藏 |
2022-09-07T06:39:22Z |
Presence of tablet remnants of nevirapine extended-release in stools and its impact on virological outcome in HIV-1-infected patients: A prospective cohort study
|
Lee Y.-C.; SHU-WEN LIN; Chen M.-Y.; Chang S.-Y.; Kuo C.-H.; Sheng W.-H.; Hsieh S.-M.; Sun H.-Y.; Chang H.-Y.; Wu M.-R.; Liu W.-C.; Wu P.-Y.; Yang S.-P.; Zhang J.-Y.; Su Y.-C.; Luo Y.-Z.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2022-09-07T06:39:19Z |
An on-spot internal standard addition approach for accurately determining colistin A and colistin B in dried blood spots using ultra high-performance liquid chromatography–tandem mass spectrometry
|
Tsai I.-L.; Kuo C.-H.; Sun H.-Y.; Chuang Y.-C.; Chepyala D.; SHU-WEN LIN; Tsai Y.-J. |
| 臺大學術典藏 |
2022-09-07T06:39:18Z |
Treatment response to unboosted atazanavir in combination with tenofovir disoproxil fumarate and lamivudine in human immunodeficiency virus-1-infected patients who have achieved virological suppression: A therapeutic drug monitoring and pharmacogenetic study
|
Tsai M.-S.; Chang S.-Y.; SHU-WEN LIN; Kuo C.-H.; Sun H.-Y.; Wu B.-R.; Tang S.-Y.; Liu W.-C.; Su Y.-C.; Hung C.-C.; Chang S.-C. |
